237880 — Clio Cosmetics Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩559bn
- KR₩437bn
- KR₩331bn
- 95
- 40
- 100
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 83,412 | 55,201 | 87,247 | 91,091 | 123,918 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 29,828 | 30,178 | 19,823 | 17,892 | 20,921 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 140,657 | 114,392 | 131,190 | 129,714 | 170,735 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 60,083 | 50,331 | 46,538 | 60,807 | 61,707 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 236,651 | 215,008 | 234,228 | 243,885 | 279,568 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 76,177 | 49,623 | 57,124 | 44,064 | 54,105 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 91,354 | 61,945 | 66,817 | 53,509 | 65,791 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 145,297 | 153,063 | 167,411 | 190,376 | 213,777 |
Total Liabilities & Shareholders' Equity | 236,651 | 215,008 | 234,228 | 243,885 | 279,568 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |